Home › Funds › Ikarian Capital, LLC › ZURA
Ikarian Capital, LLC position in ZURA
ZURA BIO LTD · Health Care
Ikarian Capital, LLC reported holding 1,018,492 shares of ZURA (ZURA BIO LTD) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.62% of its reported portfolio and ranking #43 among its reported holdings. Ikarian Capital, LLC has disclosed ZURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's ZURA position evolved
Ikarian Capital, LLC first disclosed a stake in ZURA in Q3 2025 at 2,132,322 shares (US$9.2M). Across 5 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,018,492 shares valued at US$4.2M — a reduction of -200,000 shares quarter over quarter.. Notable position changes include a 62% trim in Q4 2025 (shares rose 14% over the following quarter), a 49% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.13M | $9.23M | New |
| Q4 2025 | 802.32K | $4.20M | Reduce |
| Q1 2026 | 1.19M | $7.10M | Add |
| Q2 2026 | 1.22M | $7.19M | Add |
| Q3 2026 | 1.02M | $4.24M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO LTD) is a Health Care company. 42 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$39.3M), Venrock Adviser, LLC (US$26.8M), MPM BioImpact LLC (US$18.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $39.28M · Q3 2026
- Venrock Adviser, LLC 6.43M sh · $26.77M · Q3 2026
- MPM BioImpact LLC 4.45M sh · $18.51M · Q3 2026
- GREAT POINT PARTNERS LLC 4.08M sh · $16.96M · Q3 2026
- Commodore Capital LP 3.25M sh · $13.52M · Q3 2026
- Saturn V Capital Management LP 2.03M sh · $8.46M · Q3 2026
- Vestal Point Capital, LP 1.86M sh · $7.74M · Q3 2026
- Foresite Capital Management VI LLC 1.76M sh · $7.31M · Q3 2026
- QVT Financial LP 1.67M sh · $6.94M · Q3 2026
- Squadron Capital Management LLC 1.20M sh · $4.99M · Q3 2026
- Blue Owl Capital Holdings LP 735.00K sh · $3.06M · Q3 2026
- EcoR1 Capital, LLC 679.72K sh · $2.83M · Q3 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held ZURA?
Ikarian Capital, LLC has disclosed ZURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Ikarian Capital, LLC's current position in ZURA?
As of Q3 2026, Ikarian Capital, LLC holds 1.02M shares of ZURA (ZURA BIO LTD), valued at $4.24M, representing 0.62% of its reported portfolio and ranking #43.
Has Ikarian Capital, LLC been buying or selling ZURA?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC reduced its position in ZURA.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.